Contribution of Renal and Non-Renal Clearance on Increased Total Clearance of Adalimumab in Glomerular Disease

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

(2012) Brad H. Rovin et al.   ARTHRITIS AND RHEUMATISM

Short-Term Effects of Rituximab in Children with Steroid- and Calcineurin-Dependent Nephrotic Syndrome: A Randomized Controlled Trial

(2011) P. Ravani et al.   Clinical Journal of the American Society of Nephrology

Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up

(2011) Geertje M. Bartelds   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design

(2011) Howard Trachtman et al.   BMC Nephrology

Rituximab Therapy in Idiopathic Membranous Nephropathy: A 2-Year Study

(2010) F. C. Fervenza et al.   Clinical Journal of the American Society of Nephrology

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase 1 Trial of Adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) Study Group

(2009) Melanie S. Joy et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at university college london hospital: The first fifty patients

(2009) Tim Y.-T. Lu et al.   ARTHRITIS AND RHEUMATISM

Quality appraisal of clinical practice guidelines and consensus statements on the use of biologic agents in rheumatoid arthritis: A systematic review

(2008) Maria A. Lopez-Olivo et al.   ARTHRITIS AND RHEUMATISM

Effects of Rituximab on Morphofunctional Abnormalities of Membranous Glomerulopathy

(2008) P. Ruggenenti et al.   Clinical Journal of the American Society of Nephrology

Efficacy and safety of TNF-blocker therapy in systemic lupus erythematosus

(2008) Martin Aringer et al.   Expert Opinion On Drug Safety

Podocytes use FcRn to clear IgG from the glomerular basement membrane

(2008) S. Akilesh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Rituximab treatment of idiopathic membranous nephropathy

(2007) F.C. Fervenza et al.   KIDNEY INTERNATIONAL